Home
/
Connect Biopharma Holdings Ltd
/
Financials
/
Quarterly
Connect Biopharma Holdings Ltd — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Connect Biopharma Holdings Ltd filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$16.0K
Nov 12, 2025
Q2
2025
Jun 30, 2025
$48.0K
Aug 13, 2025
Q3
2025
Sep 30, 2024
$1.22M
Nov 12, 2025
Q2
2025
Jun 30, 2024
$24.12M
Aug 13, 2025
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($17.20M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($12.90M)
Aug 13, 2025
Q3
2025
Jun 30, 2025
($12.90M)
Nov 12, 2025
Q1
2025
Mar 31, 2025
($10.27M)
May 15, 2025
Q2
2025
Mar 31, 2025
($10.27M)
Aug 13, 2025
Q3
2025
Mar 31, 2025
($10.27M)
Nov 12, 2025
Q3
2025
Sep 30, 2024
($12.88M)
Nov 12, 2025
Q3
2025
Jun 30, 2024
$14.85M
Nov 12, 2025
Q2
2025
Jun 30, 2024
$14.85M
Aug 13, 2025
Q1
2025
Mar 31, 2024
($8.69M)
May 15, 2025
Q2
2025
Mar 31, 2024
($8.69M)
Aug 13, 2025
Q3
2025
Mar 31, 2024
($8.69M)
Nov 12, 2025
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($17.68M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($13.42M)
Aug 13, 2025
Q1
2025
Mar 31, 2025
($11.45M)
May 15, 2025
Q3
2025
Sep 30, 2024
($13.85M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
$13.65M
Aug 13, 2025
Q1
2025
Mar 31, 2024
($12.63M)
May 15, 2025